Skip to main content
Antibiotice S.A. logo

Antibiotice S.A. — Investor Relations & Filings

Ticker · ATB ISIN · ROATBIACNOR9 LEI · 315700P5G4O1L6GLMS02 RO Manufacturing
Open in API
Filings indexed 250 across all filing types
Latest filing 2025-10-01 AGM Information
Country RO Romania
Listing RO ATB

About Antibiotice S.A.

https://www.antibiotice.ro/en/

Antibiotice S.A. is a pharmaceutical company specializing in the development and manufacturing of high-quality generic medicines for human use. The company is a significant producer of anti-infective drugs, with a portfolio that includes injectable penicillins like ampicillin and nafcillin, as well as the active pharmaceutical ingredient (API) Nystatin. It operates eight GMP-certified manufacturing lines and holds US Food and Drug Administration (FDA) approval for key products, underscoring its commitment to global quality standards. The company's mission is to make valuable medicines more accessible to patients, physicians, and pharmacists by providing affordable treatments. Its product range also extends to supplements and skincare products.

Recent filings

Filing Released Lang Actions
Raport curent de informare a investitorilor
AGM Information Classification · 1% confidence The document is a 'Raport Curent' (Current Report) issued by Antibiotice S.A. in accordance with Romanian capital market regulations. It details a request from a major shareholder (Infinity Capital Investments S.A.) to supplement the agenda of an upcoming General Meeting of Shareholders (AGM/EGM) with specific items, including the election of board members via cumulative voting and changes to remuneration/contractual clauses. Since this document is a formal regulatory announcement regarding the governance and meeting agenda of the company, it falls under the category of Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information to vote on proposed agenda items.
2025-10-01 Romanian
Convocarea adunarii generale a actionarilor - RC11
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Raport Curent' (Current Report) issued by Antibiotice SA, which serves as a formal notice for the 'Convocarea Adunării Generale Ordinare a Acționarilor' (Convocation of the Ordinary General Meeting of Shareholders). It details the meeting date, agenda items (such as performance indicators and board appointments), and instructions for shareholder participation, voting, and proxy submission. This document is a standard proxy solicitation and meeting notice material, which falls under the Proxy Solicitation & Information Statement category.
2025-09-23 Romanian
Raport curent de informare a investitorilor
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a 'Raport Curent' (Current Report) from Antibiotice SA, which details the resolutions ('Hotărârile') passed during the Ordinary General Meeting of Shareholders (Adunarea Generală Ordinară a Acționarilor) held on September 17, 2025. It explicitly lists the voting results for each resolution (e.g., 'Cu voturile pentru ale acționarilor reprezentând 100%...'). Since the document provides the official outcome of the shareholder votes, it falls under the category of Declaration of Voting Results.
2025-09-17 Romanian
Plata dividend - RC17
Notice of Dividend Amount Classification · 1% confidence The document is a 'Raport Curent' (Current Report) issued by Antibiotice S.A. regarding the payment of dividends for the 2024 financial year. It specifies the dividend amount, the record date, the payment date, and the procedures for shareholders to collect their dividends. While it contains detailed instructions, it is fundamentally an announcement of the dividend payment process following a previous shareholder resolution. According to the provided filing definitions, an announcement of dividend amounts and payment details is classified as 'Notice of Dividend Amount' (DIV).
2025-09-04 Romanian
Convocarea adunarii generale a actionarilor - RC11
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Raport Curent' (Current Report) issued by Antibiotice S.A. which serves as a formal 'Convocarea Adunării Generale Ordinare a Acționarilor' (Notice of the Ordinary General Meeting of Shareholders). It outlines the agenda, meeting date, and voting procedures for shareholders. According to the filing definitions, materials sent to shareholders to provide information and request votes for meetings are classified as Proxy Solicitation & Information Statement (PSI).
2025-08-13 Romanian
Raport curent de informare a investitorilor
Report Publication Announcement Classification · 1% confidence The document is a 'Raport Curent' (Current Report) issued by Antibiotice SA. It serves as an announcement informing investors about an upcoming teleconference scheduled for August 21, 2025, regarding the presentation of financial results for the first semester of 2025. Since the document is a short announcement regarding the scheduling of a future event (a presentation) rather than the financial report itself or a transcript, it falls under the category of a Report Publication Announcement or general regulatory notification. Given the specific nature of announcing an event/presentation, 'RPA' is the most accurate classification.
2025-08-06 Romanian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.